Slide to see the difference in a real teen patient.
Actual 12-year-old clinical trial patient treated with DUPIXENT. This patient did not meet clinical trial criteria for clear or almost clear skin at 16 weeks. Individual results may vary.
Before Treatment
After Treatment with
dupixent at 16 weeks
Long-term safety results in teens aged 12 to 17 continuing on DUPIXENT through 1 year in the pediatric extension study were consistent with the adult clinical trials.
These are not all the possible side effects. Your most important partner in your teenager’s treatment is their doctor. Have open conversations with them to address any questions or concerns.